UK Experimental AMR Payment Program “On Track”

Two Antibiotics To Be Identified For Assessment By Year-End

12 Mar 2020

• By Sten Stovall

Designers of the UK’s experimental antibiotic payment system aim to identify two drugs later this year which will then undergo a novel technology assessment in 2021.

Incentives_Magnet — UK trials world's first ‘subscription’ payment model for novel antibiotics • Source: Shutterstock

Health authorities in the UK remain on track with their program for testing a "pull" reward incentive mechanism as a way to both ensure adequate supply of antibiotics - a drug class that is fast ebbing away – while stimulating innovation for new antimicrobial drugs, a process that will also use health technology evaluations of the added value from any new antimicrobial, one of the project’s team leaders told Scrip.

The AMR ‘develop and test’ program, which first launched last summer, seeks to find a balance between supply and demand...